NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Feb 20, 2015
Insider Transaction Report
Form 4
Graf Susan E
VP of Corp Dev & Strategy
Transactions
- Exercise/Conversion
Restricted Stock Units
2015-02-12−1,445→ 2,893 total→ Common Stock (1,445 underlying) - Exercise/Conversion
Common Stock
2015-02-12+1,445→ 5,245 total - Tax Payment
Common Stock
2015-02-12$45.85/sh−484$22,191→ 4,761 total - Award
Restricted Stock Units
2015-02-12+10,905→ 10,905 total→ Common Stock (10,905 underlying)
Footnotes (5)
- [F1]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
- [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]On February 12, 2014, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant.
- [F5]Restricted Stock Units will vest as follows: (i) one third will vest on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant, and (iii) one third on the third anniversary of date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.